MedTrace Logo

Japan-Drug Eluting Stents Evaluation; a Randomized Trial

NCT00708669 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3500

Last updated 2014-11-05

No results posted yet for this study

Summary

To evaluate the procedural, short and long term clinical outcomes of the TAXUS stent compared to Cypher stent in coronary arteries of ≥ 2.5 and ≤ 3.75 mm in the reference vessel diameter with a lesion of ≤ 46 mm (by visual observation) in routine clinical settings in Japan.

Conditions

Interventions

DEVICE

TAXUS stent

Compared two kinds of stents:TAXUS stent, approved for commercialization in Japan(March 30th, 2007)

DEVICE

Cypher stent

CYPHER stent, approved for commercialization in Japan(March 25, 2004)

Sponsors & Collaborators

  • Associations for Establishment of Evidence in Interventions

    lead OTHER

Principal Investigators

  • Shinsuke Nanto, M.D · Non-profit organization(NPO); "Associations for Establishment of Evidence in Intervations"

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2013-09-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00708669 on ClinicalTrials.gov